January 1997 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible.
July 2025 in “Pakistan Journal of Rehabilitation” Over half of physiotherapy students in Lahore experience hair loss, highlighting the need for better education and early treatment.
222 citations
,
September 2016 in “JCI insight” Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.
1 citations
,
September 1994 in “Hair transplant forum international” The document's content cannot be understood or processed.
6 citations
,
February 2025 in “Scientific Reports” MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.
January 2018 in “Springer eBooks” Alopecia totalis/universalis is a severe form of hair loss where all body hair is lost.
June 2026 in “Khyber Journal Of Medical Sciences” This randomized controlled trial compared the 12-week efficacy of oral tofacitinib versus methotrexate in 78 adults with severe alopecia areata, alopecia totalis, or alopecia universalis. Participants were divided into two groups, receiving either tofacitinib 10 mg twice daily or methotrexate 0.2-0.4 mg/kg once weekly. The study found that tofacitinib significantly reduced the Severity of Alopecia Tool (SALT) scores more than methotrexate, with a mean percentage improvement of 52.7% compared to 29.7%. Efficacy, defined as a >50% reduction in SALT score, was achieved by 59.0% of participants in the tofacitinib group versus 2.6% in the methotrexate group. The study concluded that tofacitinib has greater short-term efficacy, but long-term safety and other factors remain unestablished.
July 2022 in “Zenodo (CERN European Organization for Nuclear Research)” July 2022 in “Zenodo (CERN European Organization for Nuclear Research)” 20 citations
,
June 2019 in “JAAD Case Reports” Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.
September 1995 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible or understandable.
44 citations
,
October 2017 in “Journal of the American Academy of Dermatology” Tofacitinib is effective and safe for treating severe hair loss in Korean patients.
May 2025 in “JEADV Clinical Practice” Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.
March 2012 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible.
April 2013 in “e-Competitions Bulletin” In 2013, the FTC settled with hair company Bosley over claims it illegally shared business information with a competitor.
5 citations
,
June 2016 in “University of Zagreb University Computing Centre (SRCE)” Most canine follicular tumors in Croatia are benign, but some can be malignant, so testing is important.
June 2026 in “Current Oncology Reports” Sacituzumab Tirumotecan shows promise in treating gynecologic cancers with manageable side effects.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study investigated hair loss (HL) among students and faculty at a private pharmacy college in Telangana, India, involving 302 participants. The research found that 40% of participants experienced mild hair loss, while 19% reported significant hair loss. The study identified academic stress, family history, and lifestyle factors as significant contributors to hair loss, with moderate stress levels prevalent among participants. The findings highlight the need for mental health strategies to reduce stress and improve well-being, potentially addressing hair loss issues.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study investigated hair loss (HL) among students and faculty at a private pharmacy college in Telangana, India, involving 302 participants. The research found that 40% of participants experienced mild hair loss, while 19% reported significant hair loss. The study identified academic stress, family history, and lifestyle factors as significant contributors to hair loss, with moderate stress levels prevalent among participants. The findings highlight the need for mental health strategies to reduce stress and improve well-being, potentially addressing hair loss issues.
15 citations
,
December 2019 in “European Journal of Dermatology” Low-dose tofacitinib is effective and cheaper for severe alopecia areata.
1 citations
,
May 2022 in “Голова и шея.” Patients with traumatic brain injury need comprehensive care to improve their well-being.
January 2008 in “프로그램북(구 초록집)”
July 2023 in “bioRxiv (Cold Spring Harbor Laboratory)” The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.
6 citations
,
January 2021 in “Cellular and Molecular Biology” Grape pomace can be used to make valuable products with antioxidants and tocopherols.
October 2025 in “Open Repository of the University of Porto (University of Porto)” Pharmacists play a crucial role in personalized therapy, health literacy, and patient care across various health conditions.
9 citations
,
February 2018 in “Forensic Science International” The study could not confirm if Victor Vinnetou was Mbuyisa Makhubu and suggested more evidence, like DNA tests, is needed.
January 2007 in “El Servicio de Difusión de la Creación Intelectual (National University of La Plata)” Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.
May 2010 in “Hair transplant forum international” The document's content could not be processed.
June 2023 in “Zenodo (CERN European Organization for Nuclear Research)” November 2025 in “Journal of English Language and Education” Guava leaf extract hair tonic is safe, well-liked, and may help strengthen hair and scalp.